These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 16475973

  • 1. Rho GTPases: promising cellular targets for novel anticancer drugs.
    Fritz G, Kaina B.
    Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
    [Abstract] [Full Text] [Related]

  • 2. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
    Fritz G.
    Int J Oncol; 2005 Nov; 27(5):1401-9. PubMed ID: 16211237
    [Abstract] [Full Text] [Related]

  • 3. Rho GDP dissociation inhibitors as potential targets for anticancer treatment.
    Zhang B.
    Drug Resist Updat; 2006 Jun; 9(3):134-41. PubMed ID: 16807067
    [Abstract] [Full Text] [Related]

  • 4. Rho GTPases and regulation of hematopoietic stem cell localization.
    Williams DA, Zheng Y, Cancelas JA.
    Methods Enzymol; 2008 Jun; 439():365-93. PubMed ID: 18374178
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biochemical analyses of the Wrch atypical Rho family GTPases.
    Shutes A, Berzat AC, Chenette EJ, Cox AD, Der CJ.
    Methods Enzymol; 2006 Jun; 406():11-26. PubMed ID: 16472646
    [Abstract] [Full Text] [Related]

  • 7. Rho GTPases: potential candidates for anticancer therapy.
    Aznar S, Fernández-Valerón P, Espina C, Lacal JC.
    Cancer Lett; 2004 Apr 08; 206(2):181-91. PubMed ID: 15013523
    [Abstract] [Full Text] [Related]

  • 8. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB, Du W, Donover S, Baker J, Liu AX, Sharp DM, Muller AJ, Prendergast GC.
    Oncogene; 2003 Jun 05; 22(23):3578-88. PubMed ID: 12789266
    [Abstract] [Full Text] [Related]

  • 9. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics.
    Walker K, Olson MF.
    Curr Opin Genet Dev; 2005 Feb 05; 15(1):62-8. PubMed ID: 15661535
    [Abstract] [Full Text] [Related]

  • 10. Using inhibitors of prenylation to block localization and transforming activity.
    Berzat AC, Brady DC, Fiordalisi JJ, Cox AD.
    Methods Enzymol; 2006 Feb 05; 407():575-97. PubMed ID: 16757354
    [Abstract] [Full Text] [Related]

  • 11. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
    Zohn IM, Campbell SL, Khosravi-Far R, Rossman KL, Der CJ.
    Oncogene; 1998 Sep 17; 17(11 Reviews):1415-38. PubMed ID: 9779988
    [Abstract] [Full Text] [Related]

  • 12. Non-Ras targets of farnesyltransferase inhibitors: focus on Rho.
    Lebowitz PF, Prendergast GC.
    Oncogene; 1998 Sep 17; 17(11 Reviews):1439-45. PubMed ID: 9779989
    [Abstract] [Full Text] [Related]

  • 13. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ, Keller PJ, Cox AD.
    Cancer Res; 2006 Mar 15; 66(6):3153-61. PubMed ID: 16540666
    [Abstract] [Full Text] [Related]

  • 14. Potential antitumor effects of statins (Review).
    Jakobisiak M, Golab J.
    Int J Oncol; 2003 Oct 15; 23(4):1055-69. PubMed ID: 12963986
    [Abstract] [Full Text] [Related]

  • 15. Taking Rho GTPases to the next level: the cellular functions of atypical Rho GTPases.
    Aspenström P, Ruusala A, Pacholsky D.
    Exp Cell Res; 2007 Oct 15; 313(17):3673-9. PubMed ID: 17850788
    [Abstract] [Full Text] [Related]

  • 16. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY, Stafford LJ, Liu Z, Liu M, Zhang M.
    Cell Motil Cytoskeleton; 2007 May 15; 64(5):338-46. PubMed ID: 17301947
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
    Kusama T, Mukai M, Tatsuta M, Nakamura H, Inoue M.
    Int J Oncol; 2006 Jul 15; 29(1):217-23. PubMed ID: 16773203
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.